1. Antipsychotic Drugs Inhibit Platelet Aggregation via P2Y1 and P2Y12 Receptors. (16th March 2016) Authors: Wu, Chang-Chieh; Tsai, Fu-Ming; Chen, Mao-Liang; Wu, Semon; Lee, Ming-Cheng; Tsai, Tzung-Chieh; Wang, Lu-Kai; Wang, Chun-Hua Other Names: Isidori Alessandro Academic Editor. Journal: BioMed research international Issue: Volume 2016(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical stage and risk of recurrence and mortality: interaction of DNA methylation factors in patients with colorectal cancer. Issue 7 (13th June 2016) Authors: Chang, Hsien-Feng; Wu, Chang-Chieh; Sun, Chien-An; Chu, Chi-Ming; Lin, Fu-Gong; Hsieh, Jih-Fu; Hsu, Chih-Hsiung; Huang, Chi-Hua; Yang, Tsan; Tsai, Yang-Ming; Kuan, Jen-Chun; Chou, Yu-Ching Journal: Journal of investigative medicine Issue: Volume 64:Issue 7(2016) Page Start: 1200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical Stage and Risk of Recurrence and Mortality: Interaction of Dna Methylation Factors in Patients with Colorectal Cancer. Issue 7 (October 2016) Authors: Chang, Hsien-Feng; Wu, Chang-Chieh; Sun, Chien-An; Chu, Chi-Ming; Lin, Fu-Gong; Hsieh, Jih-Fu; Hsu, Chih-Hsiung; Huang, Chi-Hua; Yang, Tsan; Tsai, Yang-Ming; Kuan, Jen-Chun; Chou, Yu-Ching Journal: Journal of investigative medicine Issue: Volume 64:Issue 7(2016) Page Start: 1200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical stage and risk of recurrence and mortality: interaction of DNA methylation factors in patients with colorectal cancer. Issue 7 (October 2016) Authors: Chang, Hsien-Feng; Wu, Chang-Chieh; Sun, Chien-An; Chu, Chi-Ming; Lin, Fu-Gong; Hsieh, Jih-Fu; Hsu, Chih-Hsiung; Huang, Chi-Hua; Yang, Tsan; Tsai, Yang-Ming; Kuan, Jen-Chun; Chou, Yu-Ching Journal: Journal of investigative medicine Issue: Volume 64:Issue 7(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Determination of the UGT1A1 polymorphism as guidance for irinotecan dose escalation in metastatic colorectal cancer treated with first-line bevacizumab and FOLFIRI (PURE FIST). (October 2020) Authors: Tsai, Hsiang-Lin; Huang, Ching-Wen; Lin, Yi-Wen; Wang, Jui-Ho; Wu, Chang-Chieh; Sung, Yung-Chuan; Chen, Tzu-Liang; Wang, Hwei-Ming; Tang, Hsiu-Chin; Chen, Joe-Bin; Ke, Tao-Wei; Tsai, Chang-Sung; Huang, Hsuan-Yuan; Wang, Jaw-Yuan Journal: European journal of cancer Issue: Volume 138(2020) Page Start: 19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Prospective analysis of UGT1A1 promoter polymorphism for irinotecan dose escalation in metastatic colorectal cancer patients treated with bevacizumab plus FOLFIRI as the first-line setting: study protocol for a randomized controlled trial. Issue 1 (December 2016) Authors: Yeh, Yung-Sung; Tsai, Hsiang-Lin; Huang, Ching-Wen; Wang, Jui-Ho; Lin, Yi-Wen; Tang, Hsiu-Chih; Sung, Yung-Chuan; Wu, Chang-Chieh; Lu, Chien-Yu; Wang, Jaw-Yuan Journal: Trials Issue: Volume 17:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Sebacoyl Dinalbuphine Ester Extended-release Injection for Long-acting Analgesia: A Multicenter, Randomized, Double-Blind, And Placebo-controlled Study in Hemorrhoidectomy Patients. Issue 5 (May 2017) Authors: Yeh, Chien-Yuh; Jao, Shu-Wen; Chen, Jinn-Shiun; Fan, Chung-Wei; Chen, Hong-Hwa; Hsieh, Pao-Shiu; Wu, Chang-Chieh; Lee, Chia-Cheng; Kuo, Yi-Hung; Hsieh, Meng-Chiao; Huang, Wen-Shih; Chung, Yuan-Chiang; Liou, Tian-Yuh; Chiu, Hsi-Hsiung; Tseng, Wen-Ko; Lee, Ko-Chao; Wang, Jeng-Yi Journal: Clinical journal of pain Issue: Volume 33:Issue 5(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Tazarotene-Induced Gene 1 (TIG1) Interacts with Serine Protease Inhibitor Kazal-Type 2 (SPINK2) to Inhibit Cellular Invasion of Testicular Carcinoma Cells. (25th November 2019) Authors: Shyu, Rong-Yaun; Wang, Chun-Hua; Wu, Chang-Chieh; Wang, Lu-Kai; Chen, Mao-Liang; Kuo, Chan-Yen; Lee, Ming-Cheng; Lin, Yi-Ying; Tsai, Fu-Ming Other Names: Goldmann Torsten Academic Editor. Journal: BioMed research international Issue: Volume 2019(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗